News for Verve Therapeutics Stock (VERV)

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 10/10/24

The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline

PRNewsWire • 10/10/24

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics, Inc. Lawsuit – VERV

GlobeNewsWire • 10/09/24

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

Accesswire • 10/09/24

VERV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 10/09/24

Verve Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights – VERV

Accesswire • 10/08/24

The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc. (VERV) of a Class Action Lawsuit and an Upcoming Deadline

GlobeNewsWire • 10/08/24

The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Verve Therapeutics, Inc.

Accesswire • 10/08/24

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Verve Therapeutics, Inc. (VERV) Shareholders

Accesswire • 10/08/24

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – VERV

GlobeNewsWire • 10/08/24

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 10/08/24

Verve Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - VERV

Accesswire • 10/07/24

VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 10/07/24

VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 10/06/24

VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline

GlobeNewsWire • 10/05/24

ROSEN, LEADING INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV

GlobeNewsWire • 10/03/24

Verve Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Accesswire • 10/03/24

Verve Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – VERV

Accesswire • 10/02/24

Shareholders that lost money on Verve Therapeutics, Inc. (VERV) should contact The Gross Law Firm about pending Class Action - VERV

GlobeNewsWire • 10/02/24

The Schall Law Firm Seeks Investor Participation In A Securities Fraud Case Against Verve Therapeutics, Inc.

Accesswire • 10/02/24

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 10/02/24

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/01/24

Investors who lost money on Verve Therapeutics, Inc. (VERV) should contact Levi & Korsinsky about pending Class Action - VERV

GlobeNewsWire • 09/30/24

The Schall Law Firm Urges Investors To Take Part In A Securities Fraud Case Against Verve Therapeutics, Inc.

Accesswire • 09/30/24

Investors in Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV

PRNewsWire • 09/30/24